PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
23-Sep-2025 Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 ACCESS Newswire
23-Sep-2025 Charles River Associates (CRA) Strengthens Its Life Sciences Practice Businesswire
23-Sep-2025 Neuraxpharm participates in ECTRIMS, reinforcing its commitment to multiple sclerosis Neuraxpharm Group
23-Sep-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
23-Sep-2025 Pickering Expands Its LXI Microwave Switching Range to Serve the Latest Cross-Industry Testing Requirements Businesswire
23-Sep-2025 Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease Businesswire
23-Sep-2025 Advanced Clinical Announces Leadership Transition Businesswire
23-Sep-2025 McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day Businesswire
23-Sep-2025 Testo Saveris brings comprehensive pharma measurement system to CPHI 2025 Testo Saveris
23-Sep-2025 VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million Businesswire
23-Sep-2025 Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4® Wheat in the U.S. Businesswire
23-Sep-2025 Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies Demonstrated a Significant Improvement in Minimal Residual Disease Negativity Rates in Relapsed or Refractory Multiple Myeloma Businesswire
23-Sep-2025 Virtuoso Surgical Robotic System Receives FDA Breakthrough Device Designation Businesswire
23-Sep-2025 Lifeloc to Present at Emerging Growth Conference on September 25, 2025 ACCESS Newswire
23-Sep-2025 Drug Farm Announces Agreement with Cincinnati Children’s Hospital Medical Center to Explore ALPK1 Inhibitor, DF-003 as a Potential Treatment for Heart Disease and Blood Cancers Driven by Clonal Hematopoiesis Businesswire
23-Sep-2025 SynGenSys Introduces NK.SET Synthetic Promoter Library to Advance Natural Killer Cell Therapies Businesswire
23-Sep-2025 Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland Mainz BioMed N.V.
23-Sep-2025 The Assistance Fund Marks 100th Disease Program, Expands Support to People Living With Macular Degeneration ACCESS Newswire
23-Sep-2025 Sanofi launches Real Skinformation, an AI-powered website supporting healthcare professionals in tackling online skincare trends and misinformation Sanofi
23-Sep-2025 eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading Cell and Gene Therapy services in Southeast Asia eXmoor Pharma